| Literature DB >> 31226872 |
Sergio Di Meo1, Gaetana Napolitano2, Paola Venditti3.
Abstract
Unaccustomed and/or exhaustive exercise generates excessive free radicals and reactive oxygen and nitrogen species leading to muscle oxidative stress-related damage and impaired contractility. Conversely, a moderate level of free radicals induces the body's adaptive responses. Thus, a low oxidant level in resting muscle is essential for normal force production, and the production of oxidants during each session of physical training increases the body's antioxidant defenses. Mitochondria, NADPH oxidases and xanthine oxidases have been identified as sources of free radicals during muscle contraction, but the exact mechanisms underlying exercise-induced harmful or beneficial effects yet remain elusive. However, it is clear that redox signaling influences numerous transcriptional activators, which regulate the expression of genes involved in changes in muscle phenotype. The mitogen-activated protein kinase family is one of the main links between cellular oxidant levels and skeletal muscle adaptation. The family components phosphorylate and modulate the activities of hundreds of substrates, including transcription factors involved in cell response to oxidative stress elicited by exercise in skeletal muscle. To elucidate the complex role of ROS in exercise, here we reviewed the literature dealing on sources of ROS production and concerning the most important redox signaling pathways, including MAPKs that are involved in the responses to acute and chronic exercise in the muscle, particularly those involved in the induction of antioxidant enzymes.Entities:
Keywords: Nrf2; PGC-1; UCPs; cancer; cardiovascular disease; exercise; insulin resistance; mitochondria; neurodegenerative disorders; oxidative stress
Year: 2019 PMID: 31226872 PMCID: PMC6627449 DOI: 10.3390/ijms20123024
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Reactions by which reactive oxygen species (ROS) are produced and removed by antioxidant defense system in skeletal muscle.
Effect of exercise on markers of oxidative damage in skeletal muscle.
| Species | Activity | Marker | Ref. |
|---|---|---|---|
| Rat (6 mo) | Exhaustive treadmill running (submaximal work intensity) (gastrocnemious, soleus, plantaris) | TBARS↑ | [ |
| Rat (2 mo | Exhaustive swimming (gastrocnemious) | HPs↑, MDA↑ | [ |
| Rat (12 mo) | Exhaustive swimming (gastrocnemious) | HPs↑, MDA↑ | [ |
| Rat (4 mo) | Acute swimming (6 h) (gastrocnemious) | HPs↑, MDA↑, C=O↑, GSH/GSSG↓, C=O (mit)↑ | [ |
| Rat | Moderate and high intensity running (red and white VL) | HPs↔, MDA ↑ | [ |
| Rat | Treadmill running (20 min) | MDA↑ | [ |
| Rat | Treadmill running (1 h) (20 m/min, O% grade) | MDA (mit)↑ | [ |
| Rat | Exhaustive exercise (gastrocnemious) | C=O↑ | [ |
| Rat (8 mo, 24 mo) | Exhaustive treadmill running (25 m/min, 15 m/min, 5% grade) | MDA↑, C=O↔, GSH/GSSG↓ | [ |
| Rat (2 mo) | Exhaustive treadmill running (1.6 Km/h) (fast and slow muscle) | C=O↔, MDA↔, 8-oxodG↔ | [ |
| Dog | Treadmill running (7 h) (splenius, diaphragm, gastrocnemious) | 8-oxodG↔ | [ |
| Men (~26, ~65 yr) | Exhaustive treadmill running (45 min, 75%VO2max and 45 min, 90% VO2max) | 8-oxodG↑ | [ |
| Rat | Exhaustive treadmill running | GSH/GSSG↓ | [ |
| Men (~68 yr) | Whole-body resistance exercise training (14 wk) | 8-oxodG↓ | [ |
| Rat (2 mo) | Swim training (10 wk) (gastrocnemious) | MDA↔ | [ |
| Rat (12 mo) | Swim training (10 wk) (gastrocnemious) | MDA↔ | [ |
↔ unchanged; ↓reduced; ↑increased; mo: months; yr: years; wk: weeks; mit: mitochondria; VL: vastus lateralis.
Effect of training on antioxidant enzyme activity in skeletal muscle.
| Species | Activity | Enzymes | Ref. |
|---|---|---|---|
| Rat (2 mo) | Swim training (1 h, 10 wk) (gastrocnemious) | GPX↑, GR↑ | [ |
| Rat (12 mo) | Swim training (1 h, 10 wk) (gastrocnemious) | GPX↑, GR↑ | [ |
| Rat (50 days) | Swim training (1 h, 10 wk) (gastrocnemious) | GPX↑, GR↑ | [ |
| Mouse (2 mo) | Swim Training (1 h, 6 wk) | GPX↑, GR↑, MnSOD↔, CuZnSOD↑ | [ |
| Mouse (26 mo) | Swim training (1 h, 6 wk) | MnSOD↔, CuZnSOD↔ | [ |
| Rat | Treadmill training (32 m/min, 8%, 2 h, 12 wk) (soleus, gastrocnemious) | CAT↓, GPX↑, SOD ↔ | [ |
| Rat (2 mo) | Treadmill training (1 h, 13 wk, 50–60% of maximal exercise capacity) (soleus) | CAT↑, GPX↑, | [ |
| Rat (21 mo) | Treadmill training (1 h, 13 wk, 50–60% of maximal exercise capacity) (soleus) | CAT↔, GPX↔, | [ |
| Rat | Treadmill training (25 m/min 10%, 2 h, 10 wk) (DVL) | SOD↑, GPX↑, GR↓ | [ |
| Rat | Treadmill training (25 m/min 10%, 2 h, 10 wk) (soleus) | SOD↔, GPX↔ | [ |
| Rat (4 mo) | Treadmill training (25 m/min, 10%, 10 wk) (DVL) | GPX↑, MnSOD↔, CuZnSOD ↑ | [ |
| Rat (3 mo) | Treadmill training (27 m/min, 12% grade, 2 h, 10 wk) (SVL, soleus, plantaris) | GPX↔ CAT↔, MnSOD↔, CuZnSOD↔ | [ |
| Rat (3 mo) | Treadmill training (27 m/min, 12% grade, 2 h, 10 wk) (DVL) | GPX↑CAT↑, MnSOD↑, CuZnSOD↔ | [ |
| Men (~23 yr) | Maximal cycling sprint training (6 wk) (VL) | GPX↔ GR↔, SOD↔ | [ |
| Men (~23 yr) | Maximal cycling sprint training (7 wk) (VL) | GPX↑, GR↑, SOD↔ | [ |
| Men (~71 yr) | Unilateral resistance exercise training (12 wk) (VL) | CuZnSOD↑ MnSOD↔ CAT↑ | [ |
↔ unchanged; ↓reduced; ↑increased; mo: months; yr: years; wk: weeks; DVL: deep vastus lateralis; VL: vastus lateralis.
Figure 2Schematic model of transcriptional activity of nuclear factor erythroid 2-related factor 2 (Nrf2) mediates by oxidants during exercise and Nrf2 degradation in resting condition. MAF, musculoaponeurotic fibrosarcoma protein; ARE, antioxidant response element; Keap1, Kelch ECH associating protein 1; Ub, ubiquitin.
Figure 3Schematic representation of the signalling pathways that mediate the exercise- induced PGC-1 expression and mitochondrial biogenesis in skeletal muscle. PGC-1, peroxisome proliferator–activated receptor coactivator 1; NRF-1, nuclear respiratory factor 1; NRF-2, nuclear respiratory factor 2; ATF2, activating transcription factor 2; MEF2, myocyte enhancer factor-2; cAMP, cyclic adenosine monophosphate; CREB, cAMP response element-binding protein; CRTC, cAMP-regulated transcriptional co-activators; AMPK, AMP-activated protein kinase; PKA, protein kinase A; NO•, nitric oxide; eNOS, endothelial nitric oxide synthase; CAMK, Ca2+/calmodulin-dependent protein kinase; p38, p38 mitogen-activated protein kinases; JNK, c-Jun N-terminal kinase; ASK-1, apoptosis signal-regulating kinase-1.